Tyler Curiel, M.D., MPH, Laboratory
Dr. Curiel currently treats adult patients with hematologic malignancies, leukemias, lymphomas, multiple myelomas as well as ovarian cancer and Hepatitis C. Dr. Curiel's current research includes trials for ovarian cancer and a prostate cancer vaccine.
Tulane School of Medicine
Department of Medicine
Section of Hematology/Oncology
1430 Tulane Ave., SL-78
New Orleans, Louisiana 70112-2699
Phone: 504-588-5482
FAX: 504-588-5483
email: tcuriel@tulane.edu
Blockade
of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
Curiel TJ, Wei S, Dong H, Alvarez
X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC,
David O, Burow M, Gordon A, Dhurandhar
N, Myers L, Berggren R, Hemminki A, Alvarez RD, Emilie D, Curiel DT, Nature Med., 2003 May;9(5):562-7.
Toxoplasma gondii-Infected
Human Myeloid Dendritic Cells Induce T-Lymphocyte Dysfunction and
Contact-Dependent Apoptosis
Shuang Wei,1† Florentina Marches,1 Jozef Borvak,1 Weiping Zou,1† Jacqueline Channon, 2 Michael White,3 Jay Radke,3 Marie-France Cesbron-Delauw,4
and Tyler J. Curiel5* Infection and Immunity, Apr. 2002, p. 1750–1760.
Pyridinylimidazole p38 mitogen-activated
protein kinase inhibitors block intracellular Toxoplama gondii
replication
Shuang Wei, Florentina Marches, Ben Daniel, Sabrina Sonda,
Kim Heidenreich, Tyler Curiel International Journal for Parisitology, 32 (2002) 969-977.
Targeted adenoviral vectors
Brian G. Barnett a,b, C. Jefferson Crews a, Joanne T. Douglas
a,b,* Biochimica et Biophysica Acta, 1575 (2002) 1 – 14.
Stromal-derived
factor-1 in human tumors recruits and alters the function of plasmacytoid
precursor dendritic cells
Weiping Zou 1,2, Véronique Machelon3, Aurore Coulomb-L'Hermin4,
Jozef Borvak2, Françoise Nome3, Tatyana Isaeva2, Shuang Wei,1,2, Roman Krzysiek5, Ingrid Durand-Gasselin5, Alan Gordon6, Terri Pustilnik7,David T. Curiel7, Pierre Galanaud5, Frédérique Capron4, Dominique Emilie5 &Tyler J. Curiel1 Nature Medicine, volume 7, number 12, December 2001.
Macrophage-Derived
Dendritic Cells Have Strong Th1-Polarizing Potential Mediated by b-Chemokines
Rather Than IL-12
Weiping Zou,* Jozef Borvak,* Florentina Marches,* Shuang Wei,*
Pierre Galanaud,†Dominique Emilie,† and Tyler J. Curiel2*
Journal of Immunology, 2000, 165: 4388-4396.
Section of Hematology and Medical Oncology Laboratories
Homepage
Tulane
School of Medicine, Tulane Department
of Medicine,
Section of Hematology
and Medical Oncology,
Tulane Cancer Center